The company registered revenue growth of 52% in the UK with sales growth in both the on and off trade channels, while its US expansion recorded a 21% revenue boost.
Fever-Tree also saw a 24% revenue rise in continental Europe and Tim Warrillow, co-founder and CEO of Fever-Tree emphasised the importance of the US for the company’s future growth.
"We have seen very strong momentum across the business during 2018,” said Warrillow. “The UK delivered an exceptional performance while Europe has seen positive performance resulting in growth accelerating in the second half. We are particularly encouraged by the progress to date in the US and the strong platform for further growth this provides.
“The progress we have seen during the last 12 months means we enter 2019 very well positioned and remain optimistic about the long-term global opportunity ahead.”
